Cas:1046079-35-9 5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride manufacturer & supplier

Chemical Name:5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride

CAS.NO:1046079-35-9

Synonyms:1,3,4-Oxadiazol-2(3H)-one, 5-(4-piperidinyl)-, hydrochloride (1:1);5-piperidin-4-yl-3H-1,3,4-oxadiazol-2-one,hydrochloride;5-(4-Piperidinyl)-1,3,4-oxadiazol-2(3H)-one hydrochloride (1:1);5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride (1:1)

Molecular Formula:C₇H₁₂ClN₃O₂

Molecular Weight:205.642

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:71.18000

Exact Mass:205.061798

LogP:1.37300

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,3,4-Oxadiazol-2(3H)-one, 5-(4-piperidinyl)-, hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3,4-Oxadiazol-2(3H)-one, 5-(4-piperidinyl)-, hydrochloride (1:1) Use and application,5-(4-Piperidinyl)-1,3,4-oxadiazol-2(3H)-one hydrochloride (1:1) technical grade,usp/ep/jp grade.

Related News: US citizens who’ve been in other parts of mainland China in the last 14 days will undergo screening at US ports of entry and up to 14 days of self-monitoring. 5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride manufacturer US citizens who’ve been in other parts of mainland China in the last 14 days will undergo screening at US ports of entry and up to 14 days of self-monitoring. 5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride supplier Government prosecutors often consider whether a corporation made a genuine effort to investigate and address potentially illegal activities once learning of them. 5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride vendor Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend. 5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride factory Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.